First Alter Pharma product hits the US market: Sandoz launches generic injectable acetaminophen developed by Milla Pharmaceuticals
Sandoz generic injectable acetaminophen, developed by Milla Pharmaceuticals (member of the Alter Pharma Group), immediately available to US patients upon launch
On 8 December 2020, Sandoz announced the US launch of its generic injectable acetaminophen (paracetamol IV), available as 100 mL glass vial containing 1,000 mg acetaminophen (10 mg/mL). The generic drug is used in adult and pediatric patients of two years and older to relieve mild to moderate pai...
Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering
Dec 08, 2020
Acetaminophen injection used in patients 2 years and older to treat mild to moderate pain, moderate to severe pain in conjunction with opioid analgesics, or to reduce fever1Provides US healthcaresystem a more affordable treatment option for a key medicine stocked in every US hospital and clinic
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance